Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 1

Conditions

Uterine Cervical Neoplasms 4Stomach Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphatic Metastasis 1Hypoxia 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Bile Duct Neoplasms 1

Interventions

pembrolizumab 37Paclitaxel 18Cisplatin 18Carboplatin 14Nivolumab 13Hyperthermic Intraperitoneal Chemotherapy 13Docetaxel 11Cyclophosphamide 11Oxaliplatin 9Irinotecan 9Fluorouracil 9atezolizumab 8Trastuzumab 8Leucovorin 8Bevacizumab 8fludarabine 7Magnetic Resonance Spectroscopy 7Specimen Handling 6Ipilimumab 6Gemcitabine 6Mitomycin 5Cytoreduction Surgical Procedures 5Capecitabine 5durvalumab 4cemiplimab 4aldesleukin 4Taxes 4Psychiatric Rehabilitation 4Platinum 4Drug Therapy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Positron Emission Tomography Computed Tomography × Gynecologic × Clear all
NCT05172310 2021-12-29

PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI

Karolinska University Hospital

Phase 1 Recruiting
410 enrolled
GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡